Skip to main content
Sanofi India Ltd logo

Sanofi India Ltd — Investor Relations & Filings

Ticker · SANOFI ISIN · INE058A01010 LEI · 335800VFWLEY5V6PYH80 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2021-04-27 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS SANOFI

About Sanofi India Ltd

https://www.sanofi.in

Sanofi India Ltd focuses on the development, manufacturing, and marketing of a wide range of pharmaceutical products and healthcare solutions. The company operates across several therapeutic areas, including diabetes, cardiology, thrombosis, central nervous system disorders, and consumer healthcare. Its product portfolio includes established brands such as Lantus, Allegra, Combiflam, Amaryl, Avil, and Enterogermina. The organization prioritizes chronic disease management and acute care through a combination of prescription medicines and over-the-counter treatments. By integrating global research capabilities with local manufacturing excellence, the company provides specialized medical solutions aimed at improving patient health outcomes and addressing unmet medical needs.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges (Bombay Stock Exchange and National Stock Exchange of India) dated 27th April 2021. It announces the approval of unaudited financial results for the quarter ended 31st March 2021 by the Board of Directors. It references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The document includes the unaudited financial results and a Limited Review Report. The document length is 1858 characters, which is relatively short but contains actual financial data and the limited review report, indicating it is not merely an announcement of a report but the report itself. Therefore, this document is an Interim / Quarterly Report (IR). Q4 2021
2021-04-27 English
We refer to our letter dated 14th April 2021 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 12.00 noon and concluded at 1.45 ....
Interim / Quarterly Report Classification · 95% confidence The document is a letter addressed to stock exchanges (Bombay Stock Exchange and National Stock Exchange of India) dated 27th April 2021. It announces the approval of unaudited financial results for the quarter ended 31st March 2021 by the Board of Directors. It references Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to quarterly financial results disclosures. The document includes the unaudited financial results and a Limited Review Report. The length of the document is 1858 characters, which is relatively short but contains actual financial data and the limited review report, not just an announcement of a report publication. Therefore, it is a quarterly financial report containing substantive financial data for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report (IR). Q4 2021
2021-04-27 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-19 English
Pursuant to Regulation 40 (9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith Certificate of M/s. Makarand M. Joshi & Co., Company Secretaries ....
Regulatory Filings Classification · 95% confidence The document is a certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the half year ended 31st March 2021. It is a compliance certificate related to share transfer processes and does not contain financial statements or detailed financial data. The document is relatively short (2828 characters) and is a formal attestation by a company secretary firm. It is not an annual or interim report, nor an earnings release or management discussion. It is primarily a certification letter related to regulatory compliance. According to the Certification Rule, such officer certifications or attestations should be classified as Regulatory Filings (RNS).
2021-04-16 English
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-16 English
Copy of Newspaper Publication
Interim / Quarterly Report Classification · 95% confidence The document contains detailed consolidated audited financial results for the quarter and year ended March 31, 2021, including revenue, profit, earnings per share, and dividend information. It also includes management commentary on corporate social responsibility asset transfer, business transfers, and updates on regulatory codes. The presence of comprehensive financial data, audit opinions, and detailed notes indicates this is a full financial report rather than a brief announcement or presentation. The document is not a short notice or announcement of a report publication but contains substantive financial statements and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). FY 2021
2021-04-15 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.